((2aS,2a1S,4aS,5S)-1-Oxo-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2a,2a1,4a,5-tetrahydro-1H-2,6-dioxacyclopenta[cd]inden-4-yl)methyl acetate
- Catalog No. :
- ACZQCV061
- CAS No. :
- 14259-45-1
- Molecular Formula :
- C18H22O11
- Molecular Weight :
- 414.36
IUPAC Name:((2aS,2a1S,4aS,5S)-1-oxo-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2a,2a1,4a,5-tetrahydro-1H-2,6-dioxacyclopenta[cd]inden-4-yl)methyl acetate
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg99%$81.00Login to see priceInquiryInquiry
50mg99%$138.00Login to see priceIn stockInquiry
100mg99%$234.00Login to see priceIn stockInquiry
250mg99%$444.00Login to see priceIn stockInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | ((2aS,2a1S,4aS,5S)-1-Oxo-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2a,2a1,4a,5-tetrahydro-1H-2,6-dioxacyclopenta[cd]inden-4-yl)methyl acetate |
|---|---|
| IUPAC Name | ((2aS,2a1S,4aS,5S)-1-oxo-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2a,2a1,4a,5-tetrahydro-1H-2,6-dioxacyclopenta[cd]inden-4-yl)methyl acetate |
| MDL No. | - |
| Molecular Formula | C18H22O11 |
| Molecular Weight | 414.36 |
| SMILES | O=C1O[C@]2([H])[C@@]3([H])[C@](C(COC(C)=O)=C2)([H])[C@H](O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)OC=C13 |
| InChI Key | IBIPGYWNOBGEMH-DILZHRMZSA-N |
| Synonym | UNII-V3CFI02X39 | IBIPGYWNOBGEMH-DILZHRMZSA-N | MFCD00673989 | EINECS 238-137-5 | NCGC00380739-01 | (2AS,4AS,5S,7BS)-4-((ACETYLOXY)METHYL)-5-(beta-D-GLUCOPYRANOSYLOXY)-2A,4A,5,7B-TETRAHYDRO-1H-2,6-DIOXACYCLOPENT(CD)INDEN-1-ONE | DTXSID70878339 | [(2aS,4aS |
| CAS No. | 14259-45-1 |
| PubChem CID | 84298 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338

